6-chloro-8-methoxy-1H-benzo[d][1,3]oxazine-2,4-dione | 1276544-69-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 6-chloro-8-methoxy-1H-benzo[d][1,3]oxazine-2,4-dione
• 英文别名: 6-chloro-8-methoxy-1H-3,1-benzoxazine-2,4-dione
• CAS: 1276544-69-4
• 化学式: C₉H₆ClNO₄
• 分子量: 227.604
• InChiKey: GASSUVYMTURYOF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-氨基-3-甲氧基苯甲酸甲酯 在 N-氯代丁二酰亚胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 N,N-二甲基甲酰胺 为溶剂， 反应 28.5h， 生成 6-chloro-8-methoxy-1H-benzo[d][1,3]oxazine-2,4-dione
  参考文献：
  名称：

  [EN] BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME
  [FR] COMPOSÉS DE BENZODIAZÉPINONE ET MÉTHODES DE TRAITEMENT LES UTILISANT

  摘要：

  该发明提供了1,4-苯并二氮杂酮化合物、药物组合物以及治疗自身免疫性疾病、慢性炎症性疾病和过度增殖性疾病的方法。例如，这些1,4-苯并二氮杂酮化合物和药物组合物被认为对治疗类风湿关节炎、移植物抗宿主病、炎症性肠病等疾病有用。

  公开号：

  WO2011035124A1

文献信息

• [EN] PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBONYLCHLORIDE COMPOUNDS<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS 1H-PYRAZOLE-5-CARBONYLCHORURES N-SUBSTITUÉS
  申请人：BASF SE

  公开号：WO2013024007A1

  公开（公告）日：2013-02-21

  The present invention relates to a process for preparing an N-substi- tuted 1 H-pyrazole-5-carbonylchloride compound of the formula (I) comprising the steps of i) deprotonating a compound of the formula (II) with a base selected from lithium-organic base having a carbon or nitrogen bound lithium or with a magnesium-organic base having a carbon bound magnesium; and ii) subjecting the product obtained in step (i) to a chlorocarbonylation by reacting it with a reagent selected from the group consisting of phosgene or a phosgene equivalent, to obtain a compound of formula (I).

  本发明涉及一种制备式(I)N-取代1H-吡唑-5-羰基氯化物的过程，包括以下步骤：i) 用选择自碳或氮与锂结合的有机锂碱或碳与镁结合的有机镁碱的碱去质子化式(II)化合物；和ii) 将步骤(i)中获得的产物经氯羰基化反应，与磷酰氯或磷酰氯等效物中选择的试剂反应，以获得式(I)化合物。
• [EN] ANILINE TYPE COMPOUNDS<br/>[FR] COMPOSÉS DE TYPE ANILINES
  申请人：BASF SE

  公开号：WO2013024008A1

  公开（公告）日：2013-02-21

  The present invention relates to compounds of the formula (I) wherein R1 and R2 independently of one another are hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C10-cycloalkyl, C3-C10-halocycloalkyl, C2-C10-alkenyl, C2-C10-haloalkenyl or together represent an aliphatic chain, or the like; R3 is halogen, cyano, C1-C8-alkyl, C1-C8- haloalkyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C1-C8-alkoxy, phenyl, or the like; R4 is hydrogen, C1-C10-alkyl, C1-C10-haloalkyl, C3-C8- cycloalkyl, C3-C8-halocycloalkyl, C2-C10-alkenyl, C2-C10-haloalkenyl, phenyl, or the like; t is 0 or 1; p is 0, 1, 2, 3 or 4. The present invention also relates to a process for preparing a compound of the formula (I) which comprises reacting a compound of the formula (II) with a compound of the formulae (III) or (IV): where t, p, R1 R3, R3 and R4 are as defined in any of claims 1 to 6 and where A- is an equivalent of an anion having a pΚB of at least 10 (determined under standard conditions in water).

  本发明涉及以下式(I)的化合物，其中R1和R2彼此独立地为氢、C1-C10-烷基、C1-C10-卤代烷基、C3-C10-环烷基、C3-C10-卤代环烷基、C2-C10-烯基、C2-C10-卤代烯基或者一起代表一个脂肪链等；R3为卤素、氰基、C1-C8-烷基、C1-C8-卤代烷基、C3-C8-环烷基、C3-C8-卤代环烷基、C2-C8-烯基、C2-C8-卤代烯基、C1-C8-烷氧基、苯基等；R4为氢、C1-C10-烷基、C1-C10-卤代烷基、C3-C8-环烷基、C3-C8-卤代环烷基、C2-C10-烯基、C2-C10-卤代烯基、苯基等；t为0或1；p为0、1、2、3或4。本发明还涉及一种制备上述式(I)化合物的方法，包括将式(II)的化合物与式(III)或(IV)的化合物反应：其中t、p、R1、R3、R3和R4如权利要求1至6中的任一所定义，A-是至少在水中标准条件下具有至少10的pΚB值的阴离子的当量。
• [EN] PROCESS FOR PREPARING N-SUBSTITUTED 1H-PYRAZOLE-5-CARBOXYLATE COMPOUNDS AND DERIVATIVES THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UN COMPOSÉ N-1 H-PYRAZOLE SUBSTITUÉ-5-CARBOXYLATE ET DE SES DÉRIVÉS
  申请人：BASF SE

  公开号：WO2013076092A1

  公开（公告）日：2013-05-30

  The present invention relates to a process for preparing an N-substituted 1 H-pyrazole- 5- carboxylate compound of the formula (l-A) comprising the steps of i) deprotonating a compound of the formula (II) in which the variables R1, R2 and r are each as defined in the description and the claims, with a magnesium-organic base having a carbon bound magnesium; and ii) subjecting the product obtained in step (i) to a carbonylation by reacting it with a reagent selected from the group consisting carbon dioxide or a carbon dioxide equivalent, to obtain a compound of formula (l-A); and it relates to further conversions to yield a N-substituted 1H-pyrazole-5-carbonyl chloride compound of the formula (I).

  本发明涉及一种制备式(l-A)的N-取代1 H-吡唑-5-羧酸酯化合物的过程，包括以下步骤：i) 用具有碳键镁的镁有机碱去质子化式(II)的化合物，其中变量R1、R2和r如描述和索赔中定义，并ii) 将步骤(i)中得到的产物经过羰基化反应，与选择自二氧化碳或二氧化碳等效物的试剂反应，得到式(l-A)的化合物；并且涉及进一步的转化以产生式(I)的N-取代1H-吡唑-5-羰基氯化物化合物。
• [EN] USE OF ANTHRANILAMIDE COMPOUNDS FOR REDUCING INSECT-VECTORED VIRAL INFECTIONS<br/>[FR] UTILISATION DE COMPOSÉS D'ANTHRANILAMIDES POUR RÉDUIRE LES INFECTIONS VIRALES VÉHICULÉES PAR LES INSECTES
  申请人：BASF SE

  公开号：WO2014079820A1

  公开（公告）日：2014-05-30

  The present invention relates to agricultural methods using anthranilamide compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and k are as defined in the description; and their mixtures. The anthranilamide compounds of formula (I) are highly suitable for methods for reducing insect-vectored viral infection and transmission in plants, methods of reducing damage to plants caused by viral infection, and methods of crop enhancement including methods for improving plant growth, vigour and yield, by application of a combination of an anthranilic bis-amide or an aminothiadiazole (ryanodine receptor modulator) insecticide and a plant activator,to compositions comprising the combinations and to plant propagation material treated therewith.

  本发明涉及使用式(I)中R1、R2、R3、R4、R5、R6、R7和k如描述中定义的蒽酰胺化合物的农业方法；以及它们的混合物。式(I)中的蒽酰胺化合物非常适用于减少植物受昆虫传播的病毒感染和传播的方法，减少病毒感染引起的植物损害的方法，以及包括改善植物生长、活力和产量的作物增强方法，通过应用蒽酰双酰胺或氨基噻二唑（莱诺啶受体调节剂）杀虫剂和植物活化剂的组合，以及包含这些组合的组合物和经处理的植物繁殖材料。
• BENZODIAZEPINONE COMPOUNDS AND METHODS OF TREATMENT USING SAME
  申请人：Glick Gary D.

  公开号：US20120232067A1

  公开（公告）日：2012-09-13

  The invention provides 1,4-benzodiazepinone compounds, pharmaceutical compositions, and methods of treating autoimmune disorders, chronic inflammatory disorders, and hyperproliferative disorders. For example, the 1,4-benzodiazepinone compounds and pharmaceutical compositions are contemplated to be useful for treating rheumatoid arthritis, graft-versus-host disease, inflammatory bowel disease, and the like.

  本发明提供了1,4-苯二氮卓酮类化合物、制药组合物以及治疗自身免疫性疾病、慢性炎症性疾病和过度增生性疾病的方法。例如，考虑到1,4-苯二氮卓酮类化合物和制药组合物可用于治疗类风湿性关节炎、移植物抗宿主病、炎症性肠病等疾病。